Doyle Wealth Management Eli Lilly & CO Transaction History

Doyle Wealth Management

$1.16 Billion
Q3 2022

A detailed history of Doyle Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Doyle Wealth Management holds 3,930 shares of LLY stock, worth $3.13 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,930

Previous 4,121 4.63%

Holding current value

$3.13 Million

Previous $1.34 Million 4.87%

% of portfolio

0.11%

Previous 0.11%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$296.48 - $337.87 $56,627 - $64,533	-191 Reduced 4.63%	3,930 $1.27 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $86,600 - $107,622	369 Added 9.83%	4,121 $1.18 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $17,088 - $21,207	76 Added 2.07%	3,752 $1.04 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $443 - $545	2 Added 0.05%	3,676 $849,000
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $361 - $467	2 Added 0.05%	3,674 $843,000
Q1 2021 May 07, 2021	SELL	$164.32 - $212.72 $1,971 - $2,552	-12 Reduced 0.33%	3,672 $686,000
Q4 2020 Feb 04, 2021	SELL	$130.46 - $172.63 $6,262 - $8,286	-48 Reduced 1.29%	3,684 $622,000
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $292 - $338	2 Added 0.05%	3,732 $552,000
Q2 2020 Aug 06, 2020	SELL	$136.42 - $164.18 $135,465 - $163,030	-993 Reduced 21.02%	3,730 $612,000
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $14,327 - $17,745	134 Added 2.92%	4,723 $621,000
Q3 2019 Nov 05, 2019	SELL	$106.79 - $116.16 $961 - $1,045	-9 Reduced 0.2%	4,589 $513,000
Q2 2019 Aug 15, 2019	SELL	$110.79 - $129.32 $5,207 - $6,078	-47 Reduced 1.01%	4,598 $509,000
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $174,088 - $204,915	1,564 Added 50.76%	4,645 $540,000
Q4 2018 Feb 08, 2019	BUY	$105.9 - $118.64 $635 - $711	6 Added 0.2%	3,081 $357,000
Q3 2018 Nov 08, 2018	BUY	$85.86 - $107.31 $13,480 - $16,847	157 Added 5.38%	3,075 $330,000
Q2 2018 Aug 08, 2018	SELL	$75.7 - $86.88 $5,526 - $6,342	-73 Reduced 2.44%	2,918 $249,000
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $8,237 - $9,723	111 Added 3.85%	2,991 $231,000
Q4 2017 Feb 07, 2018	BUY	$81.94 - $87.89 $235,987 - $253,123	2,880	2,880 $243,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Doyle Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Doyle Wealth Management with notifications on news.

Account

Doyle Wealth Management Eli Lilly & CO Transaction History